- cafead May 15, 2022 at 11:12: PM
via Arriving with lofty expectations, Eli Lilly’s Mounjaro (tirzepatide) got its call-up to the big leagues on Friday, with the FDA green-lighting the type 2 diabetes and weight-loss med.
In a competitive market, which Novo Nordisk leads, can Lilly hit a home run with a drug that was shown in clinical trials to be more effective than other diabetes treatments?
article source
In a competitive market, which Novo Nordisk leads, can Lilly hit a home run with a drug that was shown in clinical trials to be more effective than other diabetes treatments?
article source